159 related articles for article (PubMed ID: 21178862)
1. Sacral neuromodulation for the treatment of fecal incontinence: analysis of cost-effectiveness.
Indinnimeo M; Ratto C; Moschella CM; Fiore A; Brosa M; Giardina S
Dis Colon Rectum; 2010 Dec; 53(12):1661-9. PubMed ID: 21178862
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of sacral neuromodulation for faecal incontinence in The Netherlands.
van Wunnik BP; Visschers RG; van Asselt AD; Baeten CG
Colorectal Dis; 2012 Dec; 14(12):e807-14. PubMed ID: 22943485
[TBL] [Abstract][Full Text] [Related]
4. Outcome and cost analysis of sacral nerve modulation for treating urinary and/or fecal incontinence.
Leroi AM; Lenne X; Dervaux B; Chartier-Kastler E; Mauroy B; Normand LL; Grise P; Faucheron JL; Parc Y; Lehur PA; Mion F; Damon H; Barth X; Leriche A; Saussine C; Guy L; Haab F; Bresler L; Sarramon JP; Bensadoun H; Rullier E; Slim K; Sielezneff I; Mourey E; Ballanger P; Michot F
Ann Surg; 2011 Apr; 253(4):720-32. PubMed ID: 21475012
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
[TBL] [Abstract][Full Text] [Related]
6. Rectal volume tolerability and anal pressures in patients with fecal incontinence treated with sacral nerve stimulation.
Michelsen HB; Buntzen S; Krogh K; Laurberg S
Dis Colon Rectum; 2006 Jul; 49(7):1039-44. PubMed ID: 16721520
[TBL] [Abstract][Full Text] [Related]
7. Sacral nerve stimulation for fecal incontinence: external anal sphincter defect vs. intact anal sphincter.
Chan MK; Tjandra JJ
Dis Colon Rectum; 2008 Jul; 51(7):1015-24; discussion 1024-5. PubMed ID: 18484136
[TBL] [Abstract][Full Text] [Related]
8. Sacral nerve stimulation for faecal incontinence: its role in the treatment algorithm.
Matzel KE
Colorectal Dis; 2011 Mar; 13 Suppl 2():10-4. PubMed ID: 21284796
[TBL] [Abstract][Full Text] [Related]
9. Sacral nerve stimulation in fecal incontinence: are there factors associated with success?
Gourcerol G; Gallas S; Michot F; Denis P; Leroi AM
Dis Colon Rectum; 2007 Jan; 50(1):3-12. PubMed ID: 17080278
[TBL] [Abstract][Full Text] [Related]
10. Is a morphologically intact anal sphincter necessary for success with sacral nerve modulation in patients with faecal incontinence?
Melenhorst J; Koch SM; Uludag O; van Gemert WG; Baeten CG
Colorectal Dis; 2008 Mar; 10(3):257-62. PubMed ID: 17949447
[TBL] [Abstract][Full Text] [Related]
11. Sacral nerve neuromodulation is effective treatment for fecal incontinence in the presence of a sphincter defect, pudendal neuropathy, or previous sphincter repair.
Brouwer R; Duthie G
Dis Colon Rectum; 2010 Mar; 53(3):273-8. PubMed ID: 20173472
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder.
Arlandis S; Castro D; Errando C; Fernández E; Jiménez M; González P; Crespo C; Staeuble F; Rodríguez JM; Brosa M
Value Health; 2011; 14(2):219-28. PubMed ID: 21402292
[TBL] [Abstract][Full Text] [Related]
13. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study.
Tjandra JJ; Chan MK; Yeh CH; Murray-Green C
Dis Colon Rectum; 2008 May; 51(5):494-502. PubMed ID: 18278532
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of sacral nerve stimulation for faecal incontinence.
Dudding TC; Meng Lee E; Faiz O; Parés D; Vaizey CJ; McGuire A; Kamm MA
Br J Surg; 2008 Sep; 95(9):1155-63. PubMed ID: 18581439
[TBL] [Abstract][Full Text] [Related]
15. [Sacral nerve stimulation in the treatment of faecal incontinence].
Matzel KE; Bittorf B; Stadelmaier U; Hohenberger W
Chirurg; 2003 Jan; 74(1):26-32. PubMed ID: 12552402
[TBL] [Abstract][Full Text] [Related]
16. [Sacral neuromodulation in fecal continence disorders].
Ferulano GP; La Manna S; Dilillo S
Recenti Prog Med; 2002; 93(7-8):403-9. PubMed ID: 12138684
[TBL] [Abstract][Full Text] [Related]
17. Sacral nerve stimulation for faecal incontinence: patient selection, service provision and operative technique.
Dudding TC; Hollingshead JR; Nicholls RJ; Vaizey CJ
Colorectal Dis; 2011 Aug; 13(8):e187-95. PubMed ID: 21689330
[TBL] [Abstract][Full Text] [Related]
18. Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence.
Bernstein MA; Purdy CH; Becker A; Magar R
Clin Ther; 2014 Jun; 36(6):890-905.e3. PubMed ID: 24815061
[TBL] [Abstract][Full Text] [Related]
19. Sacral nerve stimulation for fecal incontinence related to obstetric anal sphincter damage.
Jarrett ME; Dudding TC; Nicholls RJ; Vaizey CJ; Cohen CR; Kamm MA
Dis Colon Rectum; 2008 May; 51(5):531-7. PubMed ID: 18301948
[TBL] [Abstract][Full Text] [Related]
20. Six years of experience with sacral nerve stimulation for fecal incontinence.
Michelsen HB; Thompson-Fawcett M; Lundby L; Krogh K; Laurberg S; Buntzen S
Dis Colon Rectum; 2010 Apr; 53(4):414-21. PubMed ID: 20305440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
